Pacific Diabetes & Endocrine Center — Honolulu, Hawaii

Pacific Diabetes & Endocrine Center is a clinical research site located in Honolulu, Hawaii, United States 96817.

Crixeo Clinical Trials Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Pacific Diabetes & Endocrine Center has participated in 15 clinical trials with 8 currently active.

Therapeutic areas: Diabetes Mellitus, Type 2, Obesity, Overweight.

Sponsors: Eli Lilly and Company, Bayer, Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pacific Diabetes & Endocrine Center?

Pacific Diabetes & Endocrine Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pacific Diabetes & Endocrine Center conducted?

Pacific Diabetes & Endocrine Center has 15 clinical trials on record, with 8 currently active. Their work covers Diabetes Mellitus, Type 2, Obesity, Overweight.

Is Pacific Diabetes & Endocrine Center accredited by Crixeo Clinical Trials?

Pacific Diabetes & Endocrine Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pacific Diabetes & Endocrine Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.